Login  
Volume 72
October 2011
Number 10

CME Activity   [top]

1295  International Consensus Group on Depression Prevention in Bipolar Disorder [CME] [Free Access]

[Full Text] [CME Activity]

Original Research   [top]

1313  Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

[Full Text]

1322  Effect of Antidepressant Medication Treatment on Suicidal Ideation and Behavior in a Randomized Trial: An Exploratory Report From the Combining Medications to Enhance Depression Outcomes Study

[Full Text]

1333  Does <em>DSM-IV</em> Already Capture the Dimensional Nature of Personality Disorders?

[Full Text]

1344  Comparative Effectiveness Clinical Trials in Psychiatry: Superiority, Noninferiority, and the Role of Active Comparators

[Full Text]

1353  A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

[Full Text]

1366  Prediction of Placebo Response in 2 Clinical Trials of Lisdexamfetamine Dimesylate for the Treatment of ADHD

[Full Text]

1376  Effectiveness and Safety of Vagus Nerve Stimulation for Severe Treatment-Resistant Major Depression in Clinical Practice After FDA Approval: Outcomes at 1 Year

[Full Text]

1390  Moral or Religious Objections to Suicide May Protect Against Suicidal Behavior in Bipolar Disorder

[Full Text]

1397  Emotional Experience and Estimates of D<sub>2</sub> Receptor Occupancy in Psychotic Patients Treated With Haloperidol, Risperidone, or Olanzapine: An Experience Sampling Study

[Full Text]

1405  A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

[Full Text]

1413  Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

[Full Text]

1423  Suicide and Prescription Rates of Intranasal Corticosteroids and Nonsedating Antihistamines for Allergic Rhinitis: An Ecological Study

[Full Text]

Commentaries   [top]

1340  Commentary: Dimensional Diagnosis and <em>DSM-5</em>

[Full Text]

1341  Commentary: The Problematic <em>DSM-5</em> Personality Disorders Proposal: Options for Plan B

[Full Text]

1350  Commentary: Another Point of View: Superiority, Noninferiority, and the Role of Active Comparators

[Full Text]

1363  Commentary: Randomized Controlled Trials of Olanzapine Treatment of Borderline Personality Disorder: Two Similar Studies With Different Results

[Full Text]

Review Article   [top]

1383  Should We Expect “Neural Signatures” for <em>DSM</em> Diagnoses? [Review]

[Full Text]

ASCP Corner   [top]

1429  ASCP Corner: Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

[Full Text]

Book Reviews   [top]

1432  Handling Children’s Aggression Constructively: Toward Taming Human Destructiveness

[Full Text]

1432  Neurology for the Non-Neurologist, 6th ed

[Full Text]

1433  Bipolar Disorder: Clinical and Neurobiological Foundations

[Full Text]

Psychiatrist.com Exclusives:Free Online Activities   [top]

31  Performance Improvement CME: Managing Schizophrenia [Free Access]

[Full Text]

32  Moderators of Antidepressant Response in Major Depression [Free Access]

[Full Text]

33  Recognizing and Diagnosing ADHD in College Students [Free Access]

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx